JP2005529082A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529082A5 JP2005529082A5 JP2003575884A JP2003575884A JP2005529082A5 JP 2005529082 A5 JP2005529082 A5 JP 2005529082A5 JP 2003575884 A JP2003575884 A JP 2003575884A JP 2003575884 A JP2003575884 A JP 2003575884A JP 2005529082 A5 JP2005529082 A5 JP 2005529082A5
- Authority
- JP
- Japan
- Prior art keywords
- deoxo
- aza
- homoerythromycin
- methyl
- pseudopolymorph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 34
- 238000000034 method Methods 0.000 claims 22
- 239000000243 solution Substances 0.000 claims 15
- 239000003960 organic solvent Substances 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 6
- 239000013078 crystal Substances 0.000 claims 5
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000008025 crystallization Effects 0.000 claims 4
- 239000000543 intermediate Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- HRKNNHYKWGYTEN-HOQMJRDDSA-N (2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)NC[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 HRKNNHYKWGYTEN-HOQMJRDDSA-N 0.000 claims 2
- -1 9 -Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A anhydride Chemical class 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 239000002994 raw material Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 1
- 229930006677 Erythromycin A Natural products 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010037075 Protozoal infections Diseases 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000001491 aromatic compounds Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000002651 drug therapy Methods 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 150000003951 lactams Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 150000004682 monohydrates Chemical class 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 150000003462 sulfoxides Chemical class 0.000 claims 1
- 150000004072 triols Chemical class 0.000 claims 1
- 150000003672 ureas Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20020231A HRP20020231A2 (en) | 2002-03-18 | 2002-03-18 | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| US39361202P | 2002-07-03 | 2002-07-03 | |
| US39470502P | 2002-07-08 | 2002-07-08 | |
| PCT/IB2003/000987 WO2003077830A2 (en) | 2002-03-18 | 2003-03-18 | 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529082A JP2005529082A (ja) | 2005-09-29 |
| JP2005529082A5 true JP2005529082A5 (OSRAM) | 2006-04-06 |
Family
ID=28045976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575884A Abandoned JP2005529082A (ja) | 2002-03-18 | 2003-03-18 | ９−デオキソ−９ａ−アザ−９ａ−メチル−９ａ−ホモエリスロマイシンＡ等構造擬似多形 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7569549B2 (OSRAM) |
| EP (2) | EP1485393B1 (OSRAM) |
| JP (1) | JP2005529082A (OSRAM) |
| KR (1) | KR20050002872A (OSRAM) |
| CN (1) | CN1642966A (OSRAM) |
| AT (1) | ATE440104T1 (OSRAM) |
| AU (1) | AU2003215779A1 (OSRAM) |
| BG (1) | BG108874A (OSRAM) |
| BR (1) | BR0308644A (OSRAM) |
| CA (1) | CA2479211A1 (OSRAM) |
| DE (1) | DE60328872D1 (OSRAM) |
| EA (1) | EA200401217A1 (OSRAM) |
| ES (1) | ES2331733T3 (OSRAM) |
| HR (2) | HRP20020231A2 (OSRAM) |
| IL (1) | IL163836A0 (OSRAM) |
| IS (1) | IS7449A (OSRAM) |
| MX (1) | MXPA04009009A (OSRAM) |
| NO (1) | NO20044341L (OSRAM) |
| NZ (1) | NZ535477A (OSRAM) |
| PL (1) | PL372468A1 (OSRAM) |
| RS (1) | RS82504A (OSRAM) |
| TN (1) | TNSN04166A1 (OSRAM) |
| WO (1) | WO2003077830A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| HRP20020614A2 (en) | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| EP1878432A1 (en) * | 2003-07-24 | 2008-01-16 | Pliva - Research and Development Ltd. | Single dose fast dissolving azithromycin |
| WO2005009447A1 (en) * | 2003-07-24 | 2005-02-03 | Pliva - Research And Development Ltd. | Single dose fast dissolving azithromycin |
| JP2007513139A (ja) | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 安定性の改善した多粒子組成物 |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| CA2547239A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Azithromycin multiparticulate dosage forms by liquid-based processes |
| CA2549225A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| JP2007513145A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 医薬用多微粒子の製造方法 |
| US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| RO107257B1 (ro) * | 1987-07-09 | 1993-10-30 | Pfizer | Procedeu de obtinere a unui dihidrat de azitromicina, cristalin |
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| ES2104386T3 (es) | 1993-05-19 | 1997-10-01 | Pfizer | Compuesto intermedio para la acitromicina. |
| HRP940251B1 (en) | 1994-04-15 | 1998-12-31 | Stjepan Mutak | Process for the preparation of azithromycin dihydrochloride |
| ES2122905B1 (es) * | 1996-07-11 | 1999-11-16 | Astur Pharma Sa | Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato). |
| PT102130A (pt) | 1998-03-13 | 1999-09-30 | Hovione Sociedade Quimica S A | Processo de preparacao de dihidrato de azitromicina |
| CN1205338A (zh) | 1998-05-08 | 1999-01-20 | 刘万忠 | 阿奇霉素水溶性盐的合成新方法及其在医药上的用途 |
| TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
| CA2245398C (en) | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| JP2002531409A (ja) * | 1998-11-30 | 2002-09-24 | テバ ファーマシューティカル インダストリーズ リミティド | アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤 |
| ATE469910T1 (de) * | 1999-06-29 | 2010-06-15 | Sandoz Ag | Azithromycinmonohydrat |
| ES2177373B1 (es) * | 1999-11-26 | 2003-11-01 | Astur Pharma Sa | Preparacion de azitromicina en su forma no cristalina |
| AU2928701A (en) | 2000-01-04 | 2001-07-16 | Teva Pharmaceutical Industries Ltd. | Preparation method of azithromycin dihydrate |
| ES2162764B1 (es) * | 2000-05-17 | 2003-04-01 | Ercros Ind Sa | Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion. |
| ATE320441T1 (de) * | 2000-07-25 | 2006-04-15 | Silanes Sa De Cv Lab | Einstufiges verfahren zur herstellung von 7,16- |
| DE60114028T2 (de) | 2000-08-23 | 2006-07-13 | Wockhardt Ltd. | Verfahren zur herstellung von wasserfreiem azithromycin |
| CA2429639C (en) | 2000-11-27 | 2009-07-14 | Biochemie S.A. | Stable azithromycin monohydrate |
| KR100491183B1 (ko) | 2001-03-21 | 2005-05-25 | 한미약품 주식회사 | 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물 |
| KR100431431B1 (ko) | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| HRP20010301A2 (en) | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
| IL158591A0 (en) | 2001-05-22 | 2004-05-12 | Pfizer Prod Inc | Crystal forms of azithromycin |
| US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| EP1455757A2 (en) | 2001-12-21 | 2004-09-15 | Pfizer Products Inc. | Methods for wet granulating azithromycin |
| IL161996A0 (en) | 2001-12-21 | 2005-11-20 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
| BR0307331A (pt) | 2002-02-01 | 2004-12-07 | Pfizer Prod Inc | Formulações granuladas a seco de azitromicina |
| ITMI20021209A1 (it) | 2002-06-04 | 2003-12-04 | Chemi Spa | Processo di preparazione di azitromicina ad elevata purezza |
-
2002
- 2002-03-18 HR HR20020231A patent/HRP20020231A2/hr not_active Application Discontinuation
-
2003
- 2003-03-17 US US10/390,573 patent/US7569549B2/en not_active Expired - Lifetime
- 2003-03-18 MX MXPA04009009A patent/MXPA04009009A/es not_active Application Discontinuation
- 2003-03-18 ES ES03744475T patent/ES2331733T3/es not_active Expired - Lifetime
- 2003-03-18 RS YU82504A patent/RS82504A/sr unknown
- 2003-03-18 AU AU2003215779A patent/AU2003215779A1/en not_active Abandoned
- 2003-03-18 DE DE60328872T patent/DE60328872D1/de not_active Expired - Fee Related
- 2003-03-18 EP EP03744475A patent/EP1485393B1/en not_active Expired - Lifetime
- 2003-03-18 BR BR0308644-5A patent/BR0308644A/pt not_active Application Discontinuation
- 2003-03-18 EP EP05023731A patent/EP1627883A1/en not_active Withdrawn
- 2003-03-18 PL PL03372468A patent/PL372468A1/xx unknown
- 2003-03-18 CN CNA038063263A patent/CN1642966A/zh active Pending
- 2003-03-18 WO PCT/IB2003/000987 patent/WO2003077830A2/en not_active Ceased
- 2003-03-18 NZ NZ535477A patent/NZ535477A/en unknown
- 2003-03-18 JP JP2003575884A patent/JP2005529082A/ja not_active Abandoned
- 2003-03-18 CA CA002479211A patent/CA2479211A1/en not_active Abandoned
- 2003-03-18 EA EA200401217A patent/EA200401217A1/ru unknown
- 2003-03-18 AT AT03744475T patent/ATE440104T1/de not_active IP Right Cessation
- 2003-03-18 IL IL16383603A patent/IL163836A0/xx unknown
- 2003-03-18 HR HR20040858A patent/HRP20040858A2/xx not_active Application Discontinuation
- 2003-03-18 KR KR10-2004-7014757A patent/KR20050002872A/ko not_active Withdrawn
-
2004
- 2004-09-03 TN TNP2004000166A patent/TNSN04166A1/en unknown
- 2004-09-14 BG BG108874A patent/BG108874A/xx unknown
- 2004-09-16 IS IS7449A patent/IS7449A/is unknown
- 2004-10-13 NO NO20044341A patent/NO20044341L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2126416C1 (ru) | Производные эритромицина, фармацевтическая композиция на их основе, способ их получения и промежуточные соединения | |
| JP3334980B2 (ja) | 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途 | |
| CN101506220B (zh) | 大环内酯合成方法 | |
| JP2013527187A (ja) | マクロライド類およびケトライド類ならびにその中間体を調製するための工程 | |
| HUP0300418A2 (hu) | Eljárás klaritromicin (II) típusú kristálymódosulatainak az előállítására | |
| US5202434A (en) | 8a-aza-8a-homoerythromycin lactams | |
| EP2471795B1 (en) | Method for preparing prasugrel | |
| JPS5853000B2 (ja) | 新規抗菌剤 | |
| EP0503949B1 (en) | Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin A | |
| MXPA04009009A (es) | Pseudopolimorfos isoestructurales de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a. | |
| WO2008010231A2 (en) | A process for the purification of topiramate | |
| JP5188520B2 (ja) | 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用 | |
| CA2062932A1 (en) | 9-deoxo-9(z)-hydroxyiminoerythromycin a and o-derivatives thereof | |
| CN102875622B (zh) | 大环内酯合成方法 | |
| EP0508725A1 (en) | Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers | |
| EP0508726A1 (en) | Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives | |
| CA2064985A1 (en) | 8a-aza-8a-homoertyhromycin cyclic lactams | |
| EP2520578A1 (en) | Process for purification of cephalosporins | |
| US7410952B2 (en) | Derivatives of azithromycin | |
| WO2006035291A1 (en) | Crystalline forms of cefdinir potassium | |
| CN101830949A (zh) | 一种阿奇霉素衍生物、其中间体及其制备方法和应用 | |
| JP2012520305A (ja) | テトラサイクリンのニトロ化 | |
| CN114075110B (zh) | 一种截短侧耳素的改性方法及其在泰妙菌素制备中的应用 | |
| JPH11515011A (ja) | アモキシリンの結晶塩の製造法 | |
| EP0508795A1 (en) | 8a-aza-8a-homoerythromycin cyclic iminoethers |